Last updated: April 24, 2026
Who Supplies Ropinirole Hydrochloride (API and Key Inputs)?
What suppliers make ropinirole hydrochloride API?
Ropinirole hydrochloride is supplied globally as the active pharmaceutical ingredient (API) by multiple specialty generics and API makers, typically under DMF/CEP frameworks for dossiers. The API is sold as ropinirole hydrochloride (CAS 624-69-9) in multiple grades (pharma and, less commonly, intermediary grades).
Typical supplier categories (market structure):
- API manufacturers: produce ropinirole hydrochloride as API (commercial supply and dossier support).
- Intermediates suppliers: supply upstream building blocks used to synthesize ropinirole.
- Finished-dose manufacturers: buy API and produce tablets under their own registrations (not the primary “API supplier,” but relevant to supply-chain continuity).
Which countries dominate commercial supply?
Most ropinirole API supply originates from established generic and API manufacturing clusters in India, China, and Europe. Procurement often routes through regional distributors that consolidate multiple DMF-holding sources.
Which API grades are typically used in procurement?
For contract buying, ropinirole hydrochloride is commonly sourced to:
- Ph. Eur. and/or USP specifications (depending on region and dossier)
- ICH Q3A/Q3B impurity expectations aligned to marketed reference products
- GMP release from licensed facilities with batch records suitable for ANDA/MAA submissions
How to identify “real” suppliers for qualification (not brokers)?
For qualification, the actionable filter is whether a supplier can provide:
- Drug Master File (DMF) / ASMF (or equivalent dossier cover)
- CEP (European Certificate of Suitability) if operating under EU pathways
- CoA, impurity profile, and stability package for the intended grade
Supplier Landscape for Ropinirole Hydrochloride
Which companies commonly appear as ropinirole API or dossier holders?
Ropinirole hydrochloride is a mature product, so supplier lists are usually distributed across:
- DMF/ASMF holders (API makers)
- High-volume generic API consolidators
- Regional pharmaceutical distributors with direct manufacturing relationships
Because supplier identification must be dossier-valid (DMF/CEP) to be operationally useful for procurement, a compliant supplier list requires dossier-backed sourcing rather than generic “sells ropinirole” directory claims.
Key Procurement Facts That Drive Supplier Selection
What specification and regulatory requirements matter most?
When buying ropinirole hydrochloride API, the qualification package typically includes:
- Identity tests (IR/UV, HPLC retention time comparisons, salt form confirmation)
- Impurity profile aligned to reference impurity set
- Assay and potency
- Water content (typically Karl Fischer or loss on drying)
- Residual solvents (ICH Q3C)
- Heavy metals (ICH Q3D) and elemental impurities
What documentation is typically required from suppliers?
Operational qualification usually requires:
- GMP certificate / manufacturing authorization
- CoA for representative batches
- DMF/ASMF letter of authorization (or proof of filing status)
- Stability data (accelerated and long-term where available)
- Regulatory history (inspection outcomes when disclosed)
Supply-Chain Benchmarks
How do suppliers differ in practical terms?
In procurement practice, the differentiators are:
- Dossier support (DMF/ASMF access, updates history)
- Impurity control maturity (repeatable impurity profile)
- Batch-to-batch consistency (assay, water, residual solvent limits)
- Lead time and min order quantities (MOQ varies by supplier grade)
Key Takeaways
- Ropinirole hydrochloride API supply is concentrated in established generic/API manufacturing regions, with qualification centered on DMF/ASMF or CEP-backed sources.
- Procurement success depends on obtaining dossier-valid documentation: GMP, CoA, impurity profile, residual solvent/water/heavy metals compliance, and stability.
- For investment- and R&D-level decisions, supplier screening should filter for regulatory dossier support rather than market directories.
FAQs
1) Is ropinirole hydrochloride supplied primarily as an API or as finished tablets?
It is supplied primarily as an API to finished-dose manufacturers, but some vendors sell finished-dose product too. For formulation and dossier work, the API supply chain matters.
2) What dossier mechanism should a qualified supplier provide?
A qualified supplier typically supports filings via DMF/ASMF (or CEP for EU-oriented pathways), and provides authorization for cross-referencing.
3) What are the most common quality documents requested?
GMP certificate, CoA, impurity profile, residual solvents, elemental impurities/heavy metals, and stability data.
4) Which regions produce the bulk of ropinirole hydrochloride API?
Commercial supply is most commonly traced to India, China, and Europe through dossier-supported manufacturing.
5) How should a buyer validate a supplier?
Validate by dossier support (DMF/ASMF or CEP), then qualify using CoA/impurity profile/stability plus repeatable QC across multiple batches.
References
- European Medicines Agency. CEP search (substance: ropinirole hydrochloride). EMA website.
- U.S. FDA. Drugs@FDA and DMF/ASMF-related regulatory resources (search guidance for API submissions). FDA website.
